Viability and apoptosis in BRAF(V600E/D) melanoma cell lines monitored by imaging - Dataset (ID:20217)

Filter results: >>>>
Small Molecule Cell Line Drug Concentration Conc Unit Time Point Time Point Unit Total Number of Cells (Nuclei) Number of Apoptotic Cells Relative Viability Mean Relative Viability Apoptosis Fraction Mean Apoptosis Fraction Replicate
Selumetinib RVH-421 0.0100
uM
24
hr
4
Selumetinib RVH-421 0.0100
uM
48
hr
1661 129 0.8005 0.8836 0.0777 0.0601 1
Selumetinib RVH-421 0.0100
uM
48
hr
1600 112 0.7775 0.8836 0.0700 0.0601 2
Selumetinib RVH-421 0.0100
uM
48
hr
1920 93 0.9546 0.8836 0.0484 0.0601 3
Selumetinib RVH-421 0.0100
uM
48
hr
2006 89 1.0016 0.8836 0.0444 0.0601 4
Selumetinib RVH-421 0.0100
uM
72
hr
8827 231 0.9850 0.9881 0.0262 0.0321 1
Selumetinib RVH-421 0.0100
uM
72
hr
9833 326 1.0894 0.9881 0.0332 0.0321 2
Selumetinib RVH-421 0.0100
uM
72
hr
8078 275 0.8941 0.9881 0.0340 0.0321 3
Selumetinib RVH-421 0.0100
uM
72
hr
8900 313 0.9840 0.9881 0.0352 0.0321 4
Selumetinib RVH-421 0.0316
uM
24
hr
1498 62 1.0388 1.0320 0.0414 0.0442 1
Selumetinib RVH-421 0.0316
uM
24
hr
1487 70 1.0251 1.0320 0.0471 0.0442 2
Selumetinib RVH-421 0.0316
uM
24
hr
3
Selumetinib RVH-421 0.0316
uM
24
hr
4
Selumetinib RVH-421 0.0316
uM
48
hr
1654 120 0.8015 0.7947 0.0726 0.0622 1
Selumetinib RVH-421 0.0316
uM
48
hr
1470 110 0.7106 0.7947 0.0748 0.0622 2
Selumetinib RVH-421 0.0316
uM
48
hr
1711 83 0.8506 0.7947 0.0485 0.0622 3
Selumetinib RVH-421 0.0316
uM
48
hr
1649 87 0.8162 0.7947 0.0528 0.0622 4
Selumetinib RVH-421 0.0316
uM
72
hr
7549 228 0.8389 0.8489 0.0302 0.0318 1
Selumetinib RVH-421 0.0316
uM
72
hr
9042 260 1.0063 0.8489 0.0288 0.0318 2
Selumetinib RVH-421 0.0316
uM
72
hr
6722 240 0.7428 0.8489 0.0357 0.0318 3
Selumetinib RVH-421 0.0316
uM
72
hr
7284 238 0.8074 0.8489 0.0327 0.0318 4
Selumetinib RVH-421 0.1000
uM
24
hr
1476 71 1.0164 1.0323 0.0481 0.0496 1
Selumetinib RVH-421 0.1000
uM
24
hr
1527 78 1.0482 1.0323 0.0511 0.0496 2
Selumetinib RVH-421 0.1000
uM
24
hr
3
Selumetinib RVH-421 0.1000
uM
24
hr
4